Effects of oral vitamin D3 supplementation in stage 3 chronic kidney disease subjects: insulin resistance syndrome and hormonal disturb interactions.
This study shows that continuous low doses (30.000 IU every month) are recommended for intermittent high doses (200.000 IU every 3 months) vitamin D supplementation. Our study suggests that the serum 25OHD profile can be considered a reliable biomarker in the bioclinic CKD status to stage stabilization and inhibit its evolution.
PMID: 29661746 [PubMed - as supplied by publisher]
Source: Annales de Biologie Clinique - Category: Biochemistry Authors: Tahar A, Zerdoumi F, Saidani M, Griene L, Koceir EA Tags: Ann Biol Clin (Paris) Source Type: research
More News: Biochemistry | Cardiology | Cardiovascular | Chronic Kidney Disease | Heart | Hormones | Insulin | Proteinuria | Study | Urology & Nephrology | Vitamin D | Vitamin D Deficiency | Vitamin D3 | Vitamins